THE FRAMINGHAM HEART STUDY
Our understanding of the above key facts about heart disease was due mainly to research known as the Framingham Heart Study (FHS), the most influential investigation in the history of modern medicine. It is a long-term, ongoing cardiovascular study on residents of the town of Framingham, Massachusetts, USA. The study began in 1948 with 5209 adult subjects from Framingham and is now on its third generation of participants. Much of our appreciation of the pathophysiology of heart disease came from the results of studies from the FHS. It established the traditional risk factors, such as high blood pressure, diabetes, and cigarette smoking for coronary heart disease. Framingham also spearheaded the study of chronic noninfectious diseases in the USA and introduced preventive medicine.
ORIGINS OF THE FRAMINGHAM HEART STUDY
In 2013, the FHS celebrated 65 years since its creation. The investigation has provided substantial insight into the epidemiology of CVD and its risk factors. The origin of the study is closely linked to the premature death of the US President Franklin D. Roosevelt from hypertensive heart disease and stroke in 1945.
On March 27, 1944, President Roosevelt was admitted to Bethesda Naval Hospital for dyspnea on exertion, diaphoresis, and abdominal distension. He was described by his cardiologist as "slightly cyanotic," with "BP of 186/108 mmHg" and a chest X-ray (CXR) showing an "increase in size of the cardiac shadow." The cardiologist, Dr. Howard Bruenn, diagnosed the President with "hypertension, hypertensive heart disease, and cardiac failure." [3] However, Dr. Bruenn had few therapeutic options to provide, suggesting digitalis and salt intake reduction. After at first rejecting the cardiologist's advice, the President eventually started digitalis with some symptom reliefs, and follow-up CXR 2 weeks later showed reduced cardiomegaly.
President Roosevelt suffered from heart failure due to untreated hypertension. His personal physician at the time was not a cardiologist, but a specialist in EENT (eye, ear, nose, throat) who insisted that the President was healthy and his blood pressure was "no more than normal for a man of his age." [3] A month after his hospital admission, Roosevelt's blood pressure had risen to 240/130 mmHg. The President died of a massive cerebral hemorrhage on April 12, 1945. [3] The death of President Roosevelt illustrates the deplorable state of our knowledge and understanding of CVD in the mid-20 th century. In the 1940s, CVDs were the number one cause of mortality among Americans, accounting for 1 in 2 deaths. Prevention and treatment were so poorly understood that "most Americans accepted early death from heart disease as unavoidable." [4] On June 16, 1948, President Harry Truman signed into law the "National Heart Act." [3] Thus, the FHS under the direction of the National Heart, Lung, and Blood Institute (NHLBI) was established and became a joint project of the NHLBI and Boston University. The objective of the FHS was to identify the common factors or characteristics that contribute to CVD by following its development over a long period in a large group of participants who had not yet developed overt symptoms of CVD or suffered a heart attack or stroke. [5] 1960
Cigarette smoking found to increase the risk of heart disease.
1961
Cholesterol level, blood pressure, and electrocardiogram abnormalities found to increase the risk of heart disease.
1967
Physical activity found to reduce the risk of heart disease and obesity to increase the risk of heart disease.
1970
High blood pressure found to increase the risk of stroke.
Atrial fibrillation increases stroke risk 5-fold.
1976
Menopause found to increase the risk of heart disease.
1978
Psychosocial factors found to affect heart disease.
1988
High levels of HDL cholesterol found to reduce risk of death.
1994
Enlarged left ventricle had shown to increase the risk of stroke.
1996
Progression from hypertension to heart failure described.
1998
Framingham Heart Study researchers identify that atrial fibrillation is associated with an increased risk of all-cause mortality.
Development of simple coronary disease prediction algorithm involving risk factor categories to allow physicians to predict multivariate coronary heart disease risk in patients without overt CHD.
1999
Lifetime risk at age 40 years of developing coronary heart disease is one in two for men and one in three for women.
2001
High-normal blood pressure is associated with an increased risk of cardiovascular disease, emphasizing the need to determine whether lowering high-normal blood pressure can reduce the risk of cardiovascular disease.
2002
Lifetime risk of developing high blood pressure in middle-aged adults is 9 in 10.
Obesity is a risk factor for heart failure.
2004
Serum aldosterone levels predict future risk of hypertension in nonhypertensive individuals.
2005
Lifetime risk of becoming overweight exceeds 70%, that for obesity approximates 1 in 2.
2006
The 
2007
Based on evaluation of a densely interconnected social network of 12,067 people assessed as part of the Framingham Heart Study, network phenomena appear to be relevant to the biologic and behavioral trait of obesity, and obesity appears to spread through social ties.
2008
Based on analysis of a social network of 12,067 people participating in the Framingham Heart Study, researchers discover that social networks exert key influences on decision to quit smoking.
Discovery by Framingham Heart Study and publication of four risk factors that raise probability of developing precursor of heart failure; new 30-year risk estimates developed for serious cardiac events.
FRAMINGHAM HEART STUDY RESEARCH MILESTONES [2]

CARDIOVASCULAR DISEASE INSIGHTS FROM THE FRAMINGHAM HEART STUDY
Momentous and revolutionary breakthroughs in the development of our knowledge in CVDs are because of insights derived from the FHS. The researchers recruited 5209 men and women between the ages of 30 and 62 years from the town of Framingham, Massachusetts, USA. [5] These subjects underwent extensive medical, physical examinations and lifestyle interviews which were later analyzed for common patterns related to CVD development. Since 1948, the subjects have continued to return to the study every 2 years for a detailed medical history, physical examination, and laboratory tests. In 1971, the study enrolled a second generation -5124 of the original participants' adult children and their spouses -to participate in similar examinations. In 1994, the need to establish a new study reflecting a more diverse community of Framingham was recognized, and the first Omni cohort of the FHS was enrolled. In April 2002, the study entered a new phase, the enrollment of the third generation of participants, the grandchildren of the Original Cohort. In 2003, the second group of Omni participants was enrolled. [5] Over the years, careful monitoring of the Framingham study population has led to the identification of the major CVD risk factors -high blood pressure, high blood cholesterol, smoking, obesity, diabetes, and physical inactivity -as well as a great deal of valuable information on the effects of related factors, such as blood triglyceride and high-density lipoprotein cholesterol levels, age, gender, and psychosocial issues. [5] The study has produced approximately 1200 articles in leading medical journals. The concept of CVD risk factors has become an integral part of the modern medical curriculum and has led to the development of effective treatment and preventive strategies in clinical practice. [5] The FHS continues to make important scientific contributions. New diagnostic technologies, such as echocardiography, carotid artery ultrasound, magnetic resonance imaging of the heart and brain, and CT scans of the heart and its vessels, have been integrated into the past and ongoing protocols. The role of genes in heart disease is currently being investigated by Framingham researchers. [5] 
LEGACY OF THE FRAMINGHAM HEART STUDY
The FHS (1) corrected clinical misconceptions; (2) revealed the impact of overt and subclinical CVD; (3) established the importance of the principle of multivariable risk factor influences on CVD, with no single essential and sufficient cause; (4) enhanced mortality statistics with population-based incidence of nonfatal cardiovascular events; (5) developed useful multivariable cardiovascular risk assessment profiles (i.e., the Framingham risk score) to minimize
2009
Framingham Heart Study cited by the American Heart Association among the top 10 cardiovascular research achievements of 2009, "Genome-wide Association Study of Blood Pressure and Hypertension: Genome-wide association study identifies eight loci associated with blood pressure".
A new genetic variant associated with increased susceptibility for atrial fibrillation, a prominent risk factor for stroke and heart failure, is reported in two studies based on data from the Framingham Heart Study
Framingham Heart Study researchers find parental dementia may lead to poor memory in middle-aged adults
Framingham Heart Study researchers find high leptin levels may protect against Alzheimer's disease and dementia 2010 Sleep apnea tied to increased risk of stroke.
2010
Framingham Heart Study researchers identify additional genes that may play a role in Alzheimer's disease.
Framingham Heart Study finds fat around the abdomen associated with smaller, older brains in middleaged adults.
Framingham Heart Study finds genes link puberty timing and body fat in women.
Having first-degree relative with atrial fibrillation associated with increased risk for this disorder.
2009-2010 Framingham Heart Study researchers contribute to discovering hundreds of new genes underlying major heart disease risk factors -body mass index, blood cholesterol, cigarette smoking, blood pressure, and glucose/diabetes.
First definitive evidence that occurrence of stroke by age 65 years in a parent increased risk of stroke in offspring by 3-fold.
possibilities of falsely reassuring or needlessly alarming many potential CVD candidates; [6] and (6) introduced the concept of preventive cardiology to physicians. The three generations of Framingham participants make this study unique. Undoubtedly, the legacy of the FHS continues with state-of-the-art research into the epidemiology and genomic etiologies of CVD, new biomarkers and imaging tools, and identifying and managing risk factors.
THE FUTURE OF HEART DISEASE
Today, we know more about how to treat coronary artery disease to lengthen and improve quality of life. We also know more about how to reduce our risk of heart disease. Future research efforts will determine the screening and intervention strategies for heart disease prevention. However, we do not yet know all. We need more models of research such as the FHS. We are still a long way from eliminating heart disease from human history.
